Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Immunoglobulin as Adjuvant Therapy for Wegener's Granulomatosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436053/all/Intravenous_immunoglobulin_as_adjuvant_therapy_for_Wegener&apos.
Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436053/all/Intravenous_immunoglobulin_as_adjuvant_therapy_for_Wegener&apos. Accessed February 8, 2026.
Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436053/all/Intravenous_immunoglobulin_as_adjuvant_therapy_for_Wegener&apos
Intravenous Immunoglobulin as Adjuvant Therapy for Wegener's Granulomatosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436053/all/Intravenous_immunoglobulin_as_adjuvant_therapy_for_Wegener&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
ID - 436053
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436053/all/Intravenous_immunoglobulin_as_adjuvant_therapy_for_Wegener&apos
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

